Revolade Tablets 12.5mg, manufactured by Novartis Pharma, contains Eltrombopag Olamine (YJ code: 3999028F1025, standard: 12.5 mg 1 tablet). It is used to increase platelet count in conditions such as chronic immune thrombocytopenia, chronic hepatitis C virus infection, and severe aplastic anemia.
Revolade Tablets 12.5mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →